These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2014-000667-40 A Randomized, Double-blind, Parallel-group, Placebo-controlled Phase 2 Trial of APD811, an Oral IP Receptor Agonist, in Patients with Pulmonary Arterial Hypertension 2017-06-22 bad-data
Ongoing 2014-003042-27 An Open-Label Extension Study of APD811-003 in Patients with Pulmonary Arterial Hypertension not-yet-due
Listed as ongoing, but also has a completion date and reported results 2015-001942-28 A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative C... 2018-02-15 bad-data
Listed as ongoing, but also has a completion date 2015-002109-12 An Extension Study of APD334-003 in Patients with Moderately to Severely Active Ulcerative Colitis 2018-10-11 bad-data
Not reported 2016-003797-40 A Phase 2a, Proof of Concept, Open-label Study Evaluating the Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients with active Skin Extra-intestinal Manifestations 2017-10-02 due-trials
Ongoing 2018-001187-33 A StuDy eVAluatiNg the EffiCacy and Safety of RalinEpag To Improve Treatment OUTCOMES in PAH Patients not-yet-due
Ongoing 2018-001189-40 A StuDy EVAluatiNg the Long-Term EffiCacy and Safety of RalinEpag in Subjects with PAH via an Open-Label EXTENSION not-yet-due